Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
McKesson
UBS
Farmers Insurance
QuintilesIMS
Chubb
Citi
US Department of Justice
Covington

Generated: February 21, 2018

DrugPatentWatch Database Preview

Clarithromycin - Generic Drug Details

« Back to Dashboard

What are the generic sources for clarithromycin and what is the scope of clarithromycin patent protection?

Clarithromycin
is the generic ingredient in three branded drugs marketed by Abbvie, Sandoz, Sun Pharm Inds Ltd, Actavis Labs Fl Inc, Allied Pharma Inc, Idt Australia Ltd, Lupin Ltd, Mayne Pharma, Ranbaxy, Apotex Corp, Aurobindo, Hec Pharm Usa Inc, Ivax Sub Teva Pharms, Mylan, Teva, West-ward Pharms Int, and Wockhardt, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for clarithromycin. Thirty-nine suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for clarithromycin

US Patents and Regulatory Information for clarithromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allied Pharma Inc CLARITHROMYCIN clarithromycin TABLET;ORAL 202710-002 Jun 10, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva CLARITHROMYCIN clarithromycin TABLET;ORAL 065155-001 May 31, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan CLARITHROMYCIN clarithromycin TABLET;ORAL 065195-001 Mar 11, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt CLARITHROMYCIN clarithromycin TABLET;ORAL 065266-001 May 31, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz CLARITHROMYCIN clarithromycin FOR SUSPENSION;ORAL 065283-002 Sep 4, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie BIAXIN clarithromycin TABLET;ORAL 050662-002 Oct 31, 1991 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Ltd CLARITHROMYCIN clarithromycin TABLET;ORAL 065174-002 Sep 24, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz CLARITHROMYCIN clarithromycin TABLET;ORAL 065136-001 Aug 25, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie BIAXIN clarithromycin FOR SUSPENSION;ORAL 050698-002 Dec 23, 1993 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int CLARITHROMYCIN clarithromycin TABLET;ORAL 065178-001 May 25, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for clarithromycin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie BIAXIN XL clarithromycin TABLET, EXTENDED RELEASE;ORAL 050775-001 Mar 3, 2000 ➤ Sign Up ➤ Sign Up
Abbvie BIAXIN XL clarithromycin TABLET, EXTENDED RELEASE;ORAL 050775-001 Mar 3, 2000 ➤ Sign Up ➤ Sign Up
Abbvie BIAXIN XL clarithromycin TABLET, EXTENDED RELEASE;ORAL 050775-001 Mar 3, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
US Department of Justice
Accenture
Covington
Boehringer Ingelheim
Harvard Business School
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot